Dataset
Sort DOJ Status 3 results for “"Epiphany Biosciences"”
Set 9
Privately Held
• Headquarters: San Francisco, CA
2 BcisL:er
2
EFTA00506071
2013-08-22
Epiphany Biosciences' Investment Thesis
• Late-stage clinical antiviral company with two attractive, high-potential candidates ... Ucensed to Reliant Pharmaceuticals -developed tablet formulation (RP-606)
• Ucensed to Epiphany Biosciences - completed key Shingles & EBV proof-of.concept Phase 2 studies
Proven antiviral activity, dinical impact, & safety in multiple Phase ... EFTA00506075
Valomaciclovir Stearate (EPB-348)
Lead Indication:
Shingles &
Shingles-Associated Pain
Epiphany
Biosciences
7
EFTA00506076
2013-08-22
EPB-348 can address the important unmet needs
of shingles
Differentiating advantages
https://www.justice.gov/epstein/files/DataSet%209/EFTA00506070.pdf
August 2013
Results by Dataset3 total